Molecular Studies of Glioblastoma
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: closed (30 May 2023) | Viewed by 5322
Special Issue Editors
Interests: cancer stem cells; tumor motility; chemoresistance and radioresistance of glioma
Special Issue Information
Dear Colleagues,
Glioblastoma is one of the most aggressive tumors and the deadliest among brain tumors, with a 5-year survival rate of only 4.6 percent. Although people are doing their best to unravel the complexity of this tumor, efforts still fall short of expectations. Therefore, in-depth study of the potential molecular mechanism of glioblastoma, looking for new treatment targets, and improving the survival rate of patients is still a top priority. This includes, but is not limited to, the signal transduction pathways, energy metabolic requirements, genetic and epigenetic characteristics of glioblastoma formation and development, the interactions between glioma cells and their microenvironments (immune cells, blood vessels or neurons/gliocytes), and the signaling mechanisms involved in these interactions.
This Special Issue will focus on reviews, comments and research papers on the molecular mechanisms of glioblastoma. It is necessary to have more in-depth insight into the molecular changes in glioblastoma, and these findings are likely to provide useful information for the design of treatments to improve the survival rate of patients.
Kind regards,
Dr. Wei-Hsiu Liu
Dr. Hsin-I Ma
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- glioblastoma
- molecular mechanism
- tumorigenesis
- glioblastoma-stem-like cells
- tumor motiltiy
- inflammation
- autophagy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.